{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:40:19Z","timestamp":1776692419510,"version":"3.51.2"},"reference-count":23,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.2217\/imt-2020-0069","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T06:30:46Z","timestamp":1591770646000},"page":"759-762","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Should Immune Checkpoint Inhibitors be Contraindicated in Lung Cancer Patients with Latent Tuberculosis?"],"prefix":"10.1080","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9702-8485","authenticated-orcid":false,"given":"Fady GH","family":"Haddad","sequence":"first","affiliation":[{"name":"Department of Hematology of\u00a0Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse","family":"Kattan","sequence":"additional","affiliation":[{"name":"Department of Hematology of\u00a0Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kattan","sequence":"additional","affiliation":[{"name":"Department of Hematology of\u00a0Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910231"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753465817750075"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2016.1123626"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"e_1_3_3_6_1","first-page":"100834","article-title":"Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: case report and review of the literature","volume":"27","author":"Petri CR","year":"2019","unstructured":"Petri CR , PatellR , BataliniF , RangachariD , HallowellRW. Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: case report and review of the literature. Respir. Med. Case Rep.27, 100834 (2019).","journal-title":"Respir. Med. Case Rep."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2018.06.016"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2018.1433877"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005667"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.12.003"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat2702"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1250LE"},{"issue":"12","key":"e_1_3_3_13_1","first-page":"2238","article-title":"Anti-PD1 antibody treatment and the development of acute pulmonary tuberculosis","volume":"11","author":"Fujita K","year":"2016","unstructured":"Fujita K , TerashimaT , MioT. Anti-PD1 antibody treatment and the development of acute pulmonary tuberculosis. J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer11(12), 2238\u20132240 (2016).","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.03.012"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00659"},{"issue":"153","key":"e_1_3_3_16_1","article-title":"Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer","volume":"28","author":"Cadranel J","year":"2019","unstructured":"Cadranel J , CanellasA , MattonLet al. Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer. Eur. Respir. Rev. Off. J. Eur. Respir. Soc.28(153), (2019).","journal-title":"Eur. Respir. Rev. Off. J. Eur. Respir. Soc."},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11046"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.12.025"},{"key":"e_1_3_3_19_1","unstructured":"World Health Organization . www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.05.106"},{"issue":"39","key":"e_1_3_3_21_1","article-title":"Next generation of immune checkpoint therapy in cancer: new developments and challenges","volume":"11","author":"Marin-Acevedo JA","year":"2018","unstructured":"Marin-Acevedo JA , DholariaB , SoyanoAE , KnutsonKL , ChumsriS , LouY. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J. Hematol. Oncol.11(39), (2018).","journal-title":"J. Hematol. Oncol."},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30674-6"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0717-7"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646875"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2020-0069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:24:38Z","timestamp":1715984678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2020-0069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.2217\/imt-2020-0069"],"URL":"https:\/\/doi.org\/10.2217\/imt-2020-0069","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-03-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}